NexgenRx Applies for Warrant Term Extension

NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) announces that
it has made application to the TSX Venture Exchange (the "Exchange") to extend
the term of all outstanding common share purchase warrants granted pursuant to
the Corporation's private placement which closed on November 26, 2010 (the
"Warrants") from thirty-six (36) months to sixty (60) months from the date of
issuance in accordance with Exchange policies. The Warrants that are the subject
of the extension application consist of an aggregate of 2,583,416 Warrants, each
with an exercise price of $0.35 per Warrant. The foregoing Warrants are set to
expire on November 26, 2013 and the application being submitted to the Exchange
is to extend the expiry date until November 26, 2015.


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com.


Caution Regarding Forward-Looking Statements - This news release contains
certain forward looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of the release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393 x803
www.nexgenrx.com